The analysis finds that there has been “no marked increase in cannabis youth by use” in the three-year period following legalization.
“The findings of this study add to the growing body of evidence that easier access to cannabis for patients with pain may reduce opioid use and partially offset expenditures for both public and private drug plans.”
“The dramatic rise in retail marijuana sales is likely not so much a reflection of increased consumer demand, but of consumers shifting from the illicit market to the above-ground legal marketplace.”
Few people contributed more to NORML and our efforts to assist the victims of marijuana prohibition during our early years than Gerry Goldstein.
Legislation permitting the possession, use, cultivation, and retail sale of cannabis takes effect this Wednesday, October 17.
Prime Minister Justin Trudeau was not always in favor of adult use legalization. In fact, for many years he opposed it. That was until he met face-to-face with NORML advocates in 2012.
Members of the Canadian House and Senate have reconciled and given final approval to C-45, sweeping legislation amending the federal Controlled Drugs and Substances Act so that those over the age of 18 may legally possess, purchase, and grow personal use quantities of cannabis.
Members of the Canadian House of Commons voted 200 to 82 to approve legislation that seeks to legalize and regulate the adult use cannabis market. Proponents of the legislation hope to have the new law in place by July 1, 2018.